Pharmacy Voice and Pfizer launch publication to share best practice in community pharmacy

Today Pharmacy Voice and Pfizer Healthy Partnerships (PHP) launch the first issue of ‘Talking Point,’ a series of publications to share best practice in community pharmacy. The publication is targeted at commissioners and those working in the community pharmacy sector aiming to inspire both audiences by outlining successful programmes, initiatives and individuals in the sector across England.

The publication will be mailed across the LPC network, to Directors of Public Health and used by both Pharmacy Voice and PHP at conferences and events throughout the autumn. An online version of the publication is hosted here.

Rob Darracott, chief executive of Pharmacy Voice commented:

“Pharmacy Voice has created Talking Point as a direct response to the many stakeholders in the NHS and beyond who recognise the great work many community pharmacy teams and are keen to see examples of best practice. The publication also responds to feedback from local pharmacy teams who have shared that it can be difficult to learn from other areas how to get great services off the ground. We hope that Talking Point, launched with Pfizer’s support, will inspire those who read it to see what is possible and ultimately to help secure better opportunities to provide more care for patients.”

Paul Wilson, commercial account director at Pfizer commented:

“Now more than ever before, it is widely recognised that pharmacists will play an increasingly integral role within our dynamic health service. However, there is work to be done to steer more appropriate use of primary care providers and easing pressure from urgent and emergency care networks. We are delighted to be working alongside Pharmacy Voice to provide a means of sharing best practice in pharmacy, bringing to life examples of delivering exceptional patient care across England. We hope this series of publications will assist in improving the integration of patient care in the community setting.”

The second issue of Talking Point will be published in January 2016. Pharmacy Voice welcomes submissions for inclusion in the publication.

Notes to editor 

For further information please contact

Pfizer Healthy Partnerships (PHP)

  • Pfizer is committed to investing in the future of pharmacy. The company’s investment is represented by Pfizer Healthy Partnerships (PHP) – a selection of tools and resources connecting pharmacists with professional and commercial support
  • PHP can benefit pharmacists by building confidence in engaging with patients, supporting business development and delivering commercial value
  • PHP has three strands:
  1. Supporting professional development – providing learning resources and skills development training
  2. Enhancing the patient experience – helping pharmacy to provide a quality patient experience with training for pharmacists and support materials for patients
  3. Delivering commercial value – helping pharmacy to realise commercial opportunities by embarking on a number of initiatives to deliver commercial value for pharmacy businesses

For further information on PHP, pharmacy professionals can visit ‘Access Pfizer for Professionals’ ( ) – the one-stop shop of valuable information for Pfizer’s dispensing customers

Pharmacy Voice
Pharmacy Voice is an association of trade bodies which brings together and speaks on behalf of community pharmacy. Pharmacy Voice is formed by the three largest community pharmacy owner associations. Together we are a stronger, unified voice for community pharmacy.

Pfizer: Working Together for a Healthier World®
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people. Our diversified global health care portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer products. Every day, Pfizer colleagues work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In the UK, Pfizer has its business headquarters in Surrey and is a major supplier of medicines to the NHS. To learn more about our commitments, please visit us at

For more information, please contact:
Pfizer Press Office
0845 300 8033

Date of preparation: September 2015